Austin Health

Title
Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice.
Publication Date
2008-08-01
Author(s)
Davey, Rachel A
Turner, Andrew G
McManus, Julie F
Chiu, W S Maria
Tjahyono, Francisca
Moore, Alison J
Atkins, Gerald J
Anderson, Paul H
Ma, Cathy
Glatt, Vaida
MacLean, Helen E
Vincent, Cristina
Bouxsein, Mary L
Morris, Howard A
Findlay, David M
Zajac, Jeffrey D
Type of document
Journal Article
DOI
10.1359/jbmr.080310
Abstract
It is well established that calcitonin is a potent inhibitor of bone resorption; however, a physiological role for calcitonin acting through its cognate receptor, the calcitonin receptor (CTR), has not been identified. Data from previous genetically modified animal models have recognized a possible role for calcitonin and the CTR in controlling bone formation; however, interpretation of these data are complicated, in part because of their mixed genetic background. Therefore, to elucidate the physiological role of the CTR in calcium and bone metabolism, we generated a viable global CTR knockout (KO) mouse model using the Cre/loxP system, in which the CTR is globally deleted by >94% but <100%. Global CTRKOs displayed normal serum ultrafiltrable calcium levels and a mild increase in bone formation in males, showing that the CTR plays a modest physiological role in the regulation of bone and calcium homeostasis in the basal state in mice. Furthermore, the peak in serum total calcium after calcitriol [1,25(OH)(2)D(3)]-induced hypercalcemia was substantially greater in global CTRKOs compared with controls. These data provide strong evidence for a biological role of the CTR in regulating calcium homeostasis in states of calcium stress.
Link
Citation
Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research; 23(8): 1182-93
Jornal Title
Journal of Bone and Mineral Research

Files:

NameSizeformatDescriptionLink